Episode 98: Opportunity Costs of Healthcare in the US
On an episode originally aired on Riverwest Radio, hosts Ashlie Benson and Kacee Ochalek talk to Dr. Vanness and Dr. Lomas about their new paper, “A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States.” They discuss how pharmaceutical products whose prices do not represent good value for money come at a cost: less affordable healthcare, employers pay more to cover employees, employees effectively get paid less, higher taxes and poorly designed incentives for R&D.